The development of HTLV-1 associated clinical manifestations, such as TSP/HAM and ATLL, occur in 2-4% of the infected population and it is still unclear why this infection remains asymptomatic in most infected carriers. Recently, it has been demonstrated that HTLV uses the Glucose transporter type 1 (GLUT1) to infect T-CD4 þ lymphocytes and that single nucleotide polymorphisms (SNP) in the GLUT1 gene are associated with diabetic nephropathy in patients with diabetes mellitus in different populations. These polymorphisms could contribute to a higher GLUT1 protein expression on cellular membrane, facilitating the entry of HTLV and its transmission cell by cell. This could result in a higher provirus load and consequently in the development of
The development of HTLV-1 associated clinical manifestations, such as TSP/HAM and ATLL, occur in 2-4% of the infected population and it is still unclear why this infection remains asymptomatic in most infected carriers. Recently, it has been demonstrated that HTLV uses the Glucose transporter type 1 (GLUT1) to infect T-CD4 þ lymphocytes and that single nucleotide polymorphisms (SNP) in the GLUT1 gene are associated with diabetic nephropathy in patients with diabetes mellitus in different populations. These polymorphisms could contribute to a higher GLUT1 protein expression on cellular membrane, facilitating the entry of HTLV and its transmission cell by cell. This could result in a higher provirus load and consequently in the development of TSP/HAM. To evaluate the role of GLUT1 gene polymorphisms in the development of TSP/HAM in HTLV-1 infected individuals, the g.22999G > T, g.15339T > C and c.-2841A > T sites were analyzed by PCR/RFLP or sequencing in 244 infected individuals and 102 normal controls. The proviral load of the HTLV-1 infected patients was also analyzed using Real Time Quantitative PCR. Genotypic and allelic frequencies of the three sites did not differ significantly between controls and HTLV-1 infected individuals. There was no difference in genotypic and allelic distributions among patients as to the presence or absence of HTLV-1 associated clinic manifestations. As regards the quantification of the provirus load, we observed a significant reduction in the asymptomatic individuals compared with the oligosymptomatic and TSP/HAM individuals.
These results suggest that g.22999G > T, g.15339T > C, and c.-2841A > T SNP do not contribute to HTLV-1 infection nor to the genetic susceptibility of TSP/HAM in Brazilian HTLV-1 infected individuals. J. Med. Virol. 81:552-557, 2009 . ß 2009 Wiley-Liss, Inc.
INTRODUCTION
The Human T-cell Lymphotropic Virus (HTLV) was discovered in 1980 [Poiesz et al., 1980; Yoshida et al., 1982] . This virus is associated with adult T-cell leukemia/lymphoma (ATLL) [Poiesz et al., 1980] and tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM) [Gessain et al., 1985; Osame et al., 1986] . The HTLV-1 infection is endemic in various parts of the world, including Japan, Africa, and South America. In Brazil, the city of Salvador, capital of the state of Bahia, has the highest HTLV-1 seroprevalence (1.76%) [Dourado et al., 2003 ].
The development of HTLV-1 associated clinic manifestations occurs in a small number of infected individuals (2-4%). Furthermore, TSP/HAM and ATLL, HTLV-1 infection has been associated to uveitis [Mochizuki et al., 1992] , arthritis [Kitajima et al., 1989] , polymyositis [Morgan et al., 1989] , and infective dermatitis [LaGrenade et al., 1990] . It is unclear why HTLV-1 infection remains asymptomatic in most infected carriers, while in some it presents a broad spectrum of disease manifestations.
It was recently discovered that HTLV envelope binding and virus entry occur as a result of a direct interaction with the glucose transporter type 1 (GLUT1), demonstrating that HTLV is able to use GLUT1 to infect T-CD4 þ lymphocytes [Coskun and Sutton, 2005; Manel et al., 2005] . In 2005, Coskun and Sutton showed that GLUT1 expression increases susceptibility to HTLV. It has been suggested that cell-tocell HTLV transmission is facilitated by a virological synapse formation that accumulates HTLV structural proteins and T-cell activation markers between infected and non-infected cells [Bangham et al., 2003] .
A G-to-T substitution at position þ22999 in intron 2 of the GLUT1 gene (g.22999G > T polymorphism), which does not cause a protein modification, and an A-to-T substitution at position -2841 (c.-2841A > T polymorphism) in the promoter region of the same gene have been associated with susceptibility to diabetic nephropathy (DN) in patients with type 1 and type 2 diabetes mellitus in different populations [Gutierrez et al., 1998; Liu et al., 1998 Liu et al., , 1999 Grzeszczak et al., 2001; Hodgkinson et al., 2005] . On the other hand, the g.15339T > C polymorphism, located in the exon 2 of GLUT1 gene, does not cause any aminoacid change and it has not been associated with susceptibility to diabetic nephropathy [Ng et al., 2002] .
Single nucleotide polymorphisms (SNP) at regulator and promoter regions of the GLUT1 gene, which have the potential to modulate the gene expression by location at transcription factors binding sites or by linkage disequilibrium with other functional polymorphisms, could influence the GLUT1 protein expression in the cell and therefore HTLV infection susceptibility. However, there are no studies in the literature focusing on the association of polymorphisms at GLUT1 gene with virus infection or manifestations. With regard to SNP, the increase in GLUT1 expression in the cell membrane could facilitate the entry of the virus and its cell-to-cell transmission, leading to a higher provirus load, and consequently to TSP/HAM development. In this context, GLUT1 gene polymorphisms could explain the different HTLV-1 associated disease manifestations and the asymptomatic status of most of the infected individuals.
To examine the role of GLUT1 gene polymorphisms in the development of TSP/HAM in HTLV-1 infected individuals, the g.22999G > T, g.15339T > C, and c.-2841A > T sites were analyzed in infected and non-infected individuals. Additionally, the provirus load of HTLV-1 was also quantified in infected patients and compared with the genotypic and allelic frequencies.
MATERIALS AND METHODS

Study Design and Population
Two hundred and forty four DNA samples from HTLV-1 infected individuals were examined: 137 (77 asymptomatic individuals, 18 oligosymptomatic and 42 TSP/HAM) were seen at the HTLV Center/Medicine School of Bahia and Public Healthy/Foundation for Science Development, Salvador, Bahia, Brazil and 107 (59 asymptomatic individuals and 48 TSP/HAM) were seen at the Hemocenter Foundation in Ribeirã o Preto, Sã o Paulo, Brazil. A total of 102 DNA samples from noninfected individuals were randomly selected from the general population of Salvador [Dourado et al., 2003 ] to obtain control frequencies. The local ethical committee's approval was obtained and all subjects provided written informal consent. The study group was classified according to their HTLV-1 clinical manifestations and infection. These are summarized as follows:
TSP/HAM patients (n ¼ 90). HTLV-1 infected individuals with a TSP/HAM diagnosis based on Osame's Motor Disability Score (OMDS): slowly progressive paraparesis caused by a symmetrical myelopathy involving predominantly the pyramidal tracts [Osame et al., 1986] .
Oligosymptomatic patients (n ¼ 18). HTLV-1 infected individuals with some neurological manifestations but not fitting the TSP/HAM criteria based on OMDS.
Asymptomatic patients (n ¼ 136). HTLV-1 infected individuals without any clinical manifestations associated to HTLV-1 infection.
Non-infected individuals (n ¼ 102). HTLV-1 non-infected individuals from the general population of Salvador.
DNA Extraction and Single Nucleotide Polymorphism Detection
Genomic DNA was extracted from peripheral blood mononuclear cells (PBMC) using a proteinase K treatment followed by a phenol-chloroform method. The analyses of the g.22999G > T and g.15339T > C polymorphisms were performed through PCR amplification followed by restriction fragment length polymorphism (RFLP) using primers and PCR conditions described previously [Ng et al., 2002] . The resulting digested fragments from g.22999G > T and g.15339T > C polymorphisms were separated by gel electrophoresis on a 1.2% and 2.0% agarose gel respectively and scored under ultraviolet light. The c.-2841A > T polymorphism analysis was performed in 180 samples (53 asymptomatic, 18 oligosymptomatic, 54 TSP/HAM and 55 normal controls) by sequencing using the following primers 5 0 GCTG-AGAATGGCCTTCCCTCAAT3 0 and 5 0 GTCTGCCTTAC-TCAGCCCATGGGTC3 0 . The measurement of the provirus load was performed in PBMC of 177 HTLV-1 infected patients by Quantitative Real Time PCR as described previously [Dehee et al., 2003] . Briefly, SK110/SK111 primers were used to amplify a 186 pb fragment of gene pool and dual TaqMan probe (5 0 FAM and 3 0 TAMRA) located at 4,829-4,858 bp of the HTLV-1 reference sequence (HTLVATK). Albumin DNA was quantified in parallel in order to determine the input cell number and was used as an endogenous reference to avoid the variation due to differences in the PBMC count or DNA extraction. Standard curve was generated using 10-fold serial dilution of a double plasmid (pcHTLV-ALB) congaing one copy of the target regions of both the HTLV-1 pol gene and the cellular albumin gene. The HTLV-1 infected human lymphocyte line MT2 was used as a control for quantification. All the samples (standard curve dilutions, the MT2 control samples, and the patient samples) were analyzed in duplicate for both HTLV-1 and albumin DNA quantification. The value for the HTLV-1 proviral load was reported as the [(HTLV-1 average copy number)/(albumin average copy number)] Â 2 Â 10 6 and expressed as the number of HTLV-1 copies per 10 6 cells.
Statistical Methods
The allelic frequencies were estimated by direct allele counting. The conformity with Hardy-Weinberg equilibrium and existence of linkage disequilibrium were tested using the Genepop v.3.4 [Raymond and Rousset, 1995] . The heterogeneity among population samples was evaluated by Fisher's exact test or by w 2 test using the BioEstat v.4.0 program [Ayres et al., 2005] . MannWhitney U test, also calculated using the BioEstat v.4.0 program [Ayres et al., 2005] , was used to compare the median HTLV-1 provirus load in infected patients. A P-value <0.05 was considered statistically significant.
RESULTS
The studied population included HTLV-1 infected individuals from the cities of Salvador and Ribeirã o Preto, Brazil and HTLV-1 non-infected individuals from the general population of Salvador. All analyses were performed separately in the HTLV-1 infected individuals from Salvador and Ribeirã o Preto. There were no differences in genotypic and allelic frequencies of the GLUT1 gene polymorphisms studied when these populations were stratified (data not shown). For this reason, the HTLV-1 infected individuals from Salvador and Ribeirã o Preto were studied in the same group.
The distribution of GLUT1 gene polymorphisms in 244 HTLV-1 infected individuals and 102 normal controls is shown in Table I , log 10 ¼ 3.74. The HTLV-1 provirus load was significantly smaller in asymptomatic carriers than in oligosymptomatic (P ¼ 0.008) and TSP/HAM (P < 0.0001) patients. However, this result was not observed when oligosymptomatic and TSP/HAM individuals (P ¼ 0.1489) were compared (data not shown). When the median provirus load was compared in HTLV-1 infected individuals with the genotypes from the analyzed polymorphisms, no statistically significant difference was observed (Fig. 1) . There were no differences in GLUT1 g.22999G > T, g.15339T > C, and c.-2841A > T genotypic and allelic distributions between HTLV-1 infected and noninfected individuals (Table I) . No associations between the investigated polymorphisms and HTLV-1 associated disease manifestations were observed (Table II) . Inclusion of asymptomatic and oligosymptomatic patients in the Non-TSP/HAM group did not alter the results: no differences in genotypic and allelic frequencies between TSP/HAM and Non-TSP/HAM patients were observed (data not shown).
In relation to the sequencing of the region corresponding to the c.-2841A > T polymorphism, a novel G-to-T substitution at À2807 position was found in 6 studied samples: 3 HTLV-1 infected individuals (2 TSP/HAM and 1 asymptomatic) and 3 non-infected individuals.
DISCUSSION
Many studies have demonstrated an association between polymorphisms at regulator and promoter regions of human genes and disease manifestation [Yoshikawa et al., 2002; Licastro et al., 2003; Sabouri et al., 2004] . In fact, it has been demonstrated that cytokine gene polymorphisms may affect protein production and lead to ''high'' or ''low'' cytokine production [Rosenwasser and Borish, 1997; Fishman et al., 1998; Sabouri et al., 2004] and also could affect marker inflammation levels [D'Aiuto et al., 2004] . Previous studies have demonstrated that polymorphism at IL-6 and IL-10 promoters, at position À634 and À592 respectively, could play a role in the pathogenesis of HAM/TSP [Nishimura et al., 2002; Sabouri et al., 2004; Gadelha et al., 2008] . It has also been demonstrated that single nucleotide polymorphisms (SNP) and haplotype frequencies, can differ in populations with different ethnic backgrounds [Fishman et al., 1998; Cox et al., 2001; Hoffmann et al., 2002; Plothow et al., 2003; Gadelha et al., 2005] .
In relation to single nucleotide polymorphisms (SNP) at GLUT1 gene, it has been suggested that they could influence the GLUT1 protein expression in the cell leading to a high or low protein production. These different phenotypes of protein production could be related to its functionality and affect its activity at cell membrane, related to glucose transport (GLUT1 primordial function) or to HTLV entry. In fact, some studies suggest that these GLUT1 human gene polymorphisms affect, either directly or indirectly, the protein glucose transport function and are related to the development of pathologies associated to glucose accumulation or absence in the cell [Liu et al., 1998 [Liu et al., , 1999 Grzeszczak et al., 2001; Hodgkinson et al., 2005] .
As regards HTLV-1 infection, this is the first study that analyses SNP in GLUT1 gene, virus infection J. Med. Virol. DOI 10.1002/jmv It has been previously demonstrated that a high HTLV-1 proviral load is associated with an increased risk of progression to disease [Nagai et al., 1998 ], progression of motor disability [Takenouchi et al., 2003] , and risk of sexual transmission of HTLV-1 [Kaplan et al., 1996] . In TSP/HAM patients from Japan, the median provirus load in peripheral blood mononuclear cells (PBMC) is more than ten times higher than in asymptomatic patients [Nagai et al., 1998 ]. In this study, it was observed that the median HTLV-1 provirus load is smaller in asymptomatic carriers than in oligosymptomatic and TSP/HAM patients suggesting that this aspect of HTLV-1 infection is associated with the development of neurological symptoms. However, we did not observe any association between the genotypes frequencies from the analyzed polymorphisms and the proviral load.
The g.15339T > C polymorphism is located in the exon 2 of GLUT1 gene and it does not cause any aminoacid change [Ng et al., 2002] . These results did not demonstrate an association between allelic and genotypic frequencies of this polymorphism and the risk of TSP/ HAM development.
The c.-2841A > T polymorphism is located next to a HIF-responsive element in the GLUT1 promoter that has the capacity to up-regulate GLUT1 expression in hypoxic conditions [Hayashi et al., 2004] . It has been recently demonstrated that Tax (HTLV-1 regulatory protein) mediates the HIF-1(Hypoxia-inducible factor-1) transcriptional activation by Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway [Tomita et al., 2007] . This mechanism could induce GLUT1 expression in HTLV-1 infected cells and facilitate its transmission. In this study, no association between c.-2841A > T polymorphism and TSP/HAM development was observed. The novel c.-2807G > T mutation was observed in 1.7% of the population studied, characterizing this mutation as a polymorphic site.
The g.22999G > T polymorphism has been associated to susceptibility to diabetic nephropathy in different populations [Liu et al., 1998 [Liu et al., , 1999 Gutierrez et al., 1998; Grzeszczak et al., 2001] . The observed results did not demonstrate any difference in genotypic and allelic frequencies between HTLV-1 infected and non-infected individuals and between HTLV-1 infected patients with a different clinic status. The association of g.22999G > T polymorphism and diabetic nephropathy has been suggested to be caused by linkage disequilibrium with other functional disease markers, since this polymorphism occurs in the intron 2 of GLUT1 gene and does not cause a protein modification [Grzeszczak et al., 2001] . In this study, a strong linkage disequilibrium of g.22999G > T and g.15339T > C polymorphisms was observed. However, as previously shown, both polymorphisms are not associated with TSP/HAM development in our population and they can not be used as markers of this pathology.
These results suggest that the g.22999G > T, g.15339T > C, and c.-2841A > T polymorphisms at GLUT1 gene, although probably related to glucose entry in the cell (g.22999G > T and c.-2841A > T polymorphisms), are not associated with HTLV-1 infection nor with TSP/HAM development, suggesting that the different activities of the GLUT1 protein (glucose transport and HTLV entry) are mediated by the protein distinct domains. However, more studies concentrated in the GLUT1 protein expression should be taken in order to investigate its major role in the development of TSP/HAM in HTLV-1 infected individuals.
